These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 32205405)

  • 1. Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Winston JA; Rivera AJ; Cai J; Thanissery R; Montgomery SA; Patterson AD; Theriot CM
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32205405
    [No Abstract]   [Full Text] [Related]  

  • 2. Clostridioides difficile infection induces a rapid influx of bile acids into the gut during colonization of the host.
    Wexler AG; Guiberson ER; Beavers WN; Shupe JA; Washington MK; Lacy DB; Caprioli RM; Spraggins JM; Skaar EP
    Cell Rep; 2021 Sep; 36(10):109683. PubMed ID: 34496241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis.
    Pike CM; Tam J; Melnyk RA; Theriot CM
    Infect Immun; 2022 Aug; 90(8):e0015322. PubMed ID: 35862710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.
    Weingarden AR; Chen C; Zhang N; Graiziger CT; Dosa PI; Steer CJ; Shaughnessy MK; Johnson JR; Sadowsky MJ; Khoruts A
    J Clin Gastroenterol; 2016 Sep; 50(8):624-30. PubMed ID: 26485102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-Dependent Inhibition of Clostridioides difficile by Commensal
    Reed AD; Nethery MA; Stewart A; Barrangou R; Theriot CM
    J Bacteriol; 2020 May; 202(11):. PubMed ID: 32179626
    [No Abstract]   [Full Text] [Related]  

  • 6. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
    Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
    J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.
    Winston JA; Theriot CM
    Anaerobe; 2016 Oct; 41():44-50. PubMed ID: 27163871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids.
    Thanissery R; Winston JA; Theriot CM
    Anaerobe; 2017 Jun; 45():86-100. PubMed ID: 28279860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
    Phan JR; Do DM; Truong MC; Ngo C; Phan JH; Sharma SK; Schilke A; Mefferd CC; Villarama JV; Lai D; Consul A; Hedlund BP; Firestine SM; Abel-Santos E
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0143521. PubMed ID: 34780262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversification of host bile acids by members of the gut microbiota.
    Winston JA; Theriot CM
    Gut Microbes; 2020; 11(2):158-171. PubMed ID: 31595814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strain of Bacteroides thetaiotaomicron attenuates colonization of Clostridioides difficile and affects intestinal microbiota and bile acids profile in a mouse model.
    Li X; Kang Y; Huang Y; Xiao Y; Song L; Lu S; Ren Z
    Biomed Pharmacother; 2021 May; 137():111290. PubMed ID: 33508620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Colonization Resistance Against Clostridioides difficile.
    Pike CM; Theriot CM
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S194-S200. PubMed ID: 33326565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
    Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
    Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifts in the Gut Metabolome and
    Fletcher JR; Erwin S; Lanzas C; Theriot CM
    mSphere; 2018; 3(2):. PubMed ID: 29600278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK; Mullish BH; Pechlivanis A; Liu Z; Brignardello J; Kao D; Holmes E; Li JV; Clarke TB; Thursz MR; Marchesi JR
    Gastroenterology; 2018 Nov; 155(5):1495-1507.e15. PubMed ID: 30025704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.
    Andersson JA; Peniche AG; Galindo CL; Boonma P; Sha J; Luna RA; Savidge TC; Chopra AK; Dann SM
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary bile acid ursodeoxycholic acid alters weight, the gut microbiota, and the bile acid pool in conventional mice.
    Winston JA; Rivera A; Cai J; Patterson AD; Theriot CM
    PLoS One; 2021; 16(2):e0246161. PubMed ID: 33600468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
    Lesniak NA; Schubert AM; Sinani H; Schloss PD
    mSphere; 2021 May; 6(3):. PubMed ID: 33952668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile salt metabolism is not the only factor contributing to
    Jukes CA; Ijaz UZ; Buckley A; Spencer J; Irvine J; Candlish D; Li JV; Marchesi JR; Douce G
    Gut Microbes; 2020 May; 11(3):481-496. PubMed ID: 31793403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.
    Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E
    Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.